Tag: AbbVie

May 14, 2019

5 Top Pharmaceutical ETFs

A wide range of investors may want to consider pharmaceutical ETFs as a way to stay informed about and invest...
April 18, 2019

Pharma Market Update: Q1 2019 in Review

With Q1 2019 officially over, the Investing News Network shares a pharma market update on the biggest news and trends...
April 16, 2019

Biotech Market Update: Q1 2019 in Review

With Q1 2019 officially over, the Investing News Network shares a biotech market update on the biggest news and trends...
March 26, 2019

7 Potential Blockbuster Drugs Investors Should Watch for in 2019

A report by Cortellis says that seven drugs entering the market in 2019 are projected to reach blockbuster status by...
February 26, 2019

Senate Finance Committee Blasts Pharma CEOs on Drug Prices

This was the largest panel of pharmaceutical executives "in decades" to appear before a congressional committee.
January 25, 2019

Coherus BioSciences Announces Global Settlement with AbbVie

Coherus BioSciences (Nasdaq:CHRS), a commercial biosimilar company, announced it has executed settlement agreements with AbbVie that grant Coherus global, non-exclusive...
January 15, 2019

Which Life Science IPOs is the Government Shutdown Affecting?

Initial public offerings meant to take place are facing a huge barrier due to the ongoing US government shutdown.